Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of Post-Herniorrhaphy Non-opioid MMA Regimens

NCT: NCT03907176 · COMPLETED

NCT IDNCT03907176
StatusCOMPLETED
Start Date2019-04-04
Completion2021-11-22
SponsorHeron Therapeutics (INDUSTRY)
First posted
Last updated

Brief Summary

This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference for MMA regimen.

Frequently Asked Questions

What is Study of Post-Herniorrhaphy Non-opioid MMA Regimens?

Study of Post-Herniorrhaphy Non-opioid MMA Regimens is a clinical trial registered under NCT03907176. Current status: COMPLETED.

What is the status of NCT03907176?

The current status of NCT03907176 (Study of Post-Herniorrhaphy Non-opioid MMA Regimens) is: COMPLETED.

When did Study of Post-Herniorrhaphy Non-opioid MMA Regimens start?

Study of Post-Herniorrhaphy Non-opioid MMA Regimens started on 2019-04-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.